首页> 外文期刊>Clinical practice and epidemiology in mental health >Pattern of benzodiazepine use in psychiatric outpatients in Pakistan: a cross-sectional survey
【24h】

Pattern of benzodiazepine use in psychiatric outpatients in Pakistan: a cross-sectional survey

机译:巴基斯坦精神科门诊患者使用苯二氮卓类药物的方式:横断面调查

获取原文
       

摘要

Background Benzodiazepines (BDZ) are the largest-selling drug group in the world. The potential of dependence with BDZ has been known for almost three decades now. In countries like Pakistan where laws against unlicensed sale of BDZ are not implemented vigorously the risk of misuse of and dependence on these drugs is even higher. Previous studies have shown that BDZ prevalence among patients/visitors to general outpatient clinics in Pakistan may be as high as 30%. However, no research has been carried out on the prevalence of BDZ use in psychiatric patients in Pakistan. Methods We carried out a cross-sectional survey over 3 months in psychiatry outpatient clinics of two tertiary care hospitals in Karachi and Lahore. Besides basic socio-demographic data the participants were asked if they were taking a BDZ at present and if yes, the frequency, route and dosage of the drug, who had initiated the drug and why it had been prescribed. We used chi-square test and t-test to find out which socio-demographic or clinical factors were associated with an increased risk of BDZ use. We used Logistic Regression to find out which variable(s) best predicted the increased likelihood of BDZ use. Results Out of a total of 419 participants 187 (45%) of the participants had been currently using at least one BDZ. Seventy-three percent of the users had been using the drug for 4 weeks or longer and 87% were taking it every day. In 90% of cases the BDZ had been initiated by a doctor, who was a psychiatrist in 70% of the cases. Female gender, increasing age, living in Lahore, and having seen a psychiatrist before, were associated with an increased likelihood of using BDZ. Conclusion The study shows how high BDZ use is in psychiatric outpatients in Pakistan. Most of the users were taking it for a duration and with a frequency which puts them at risk of becoming dependent on BDZ. In most of the cases it had been initiated by a doctor. Both patients and doctors need to be made aware of the risk of dependence associated with the use of BDZ.
机译:背景苯二氮卓类药物(BDZ)是世界上销量最大的药物组。对BDZ的依赖潜力已有近三十年的历史了。在像巴基斯坦这样的国家,没有大力实施禁止无证销售BDZ的法律,滥用和依赖这些药物的风险甚至更高。先前的研究表明,巴基斯坦普通门诊患者/访客中的BDZ患病率可能高达30%。但是,尚未对巴基斯坦精神病患者使用BDZ的患病率进行任何研究。方法我们在卡拉奇和拉合尔的两家三级医院的精神科门诊进行了为期3个月的横断面调查。除了基本的社会人口统计学数据外,还询问参与者当前是否正在服用BDZ,如果是,则询问药物的频率,途径和剂量,发起药物的人以及为什么开处方。我们使用卡方检验和t检验来找出哪些社会人口统计学或临床因素与BDZ使用风险增加有关。我们使用Logistic回归找出最能预测BDZ使用可能性增加的变量。结果在总共419名参与者中,有187名(45%)参与者目前至少使用了一个BDZ。 73%的使用者已经使用药物4周或更长时间,每天有87%的使用者服用该药物。在90%的病例中,BDZ是由医生发起的,在70%的病例中,医生是精神病医生。女性,年龄增长,居住在拉合尔以及以前看过精神病医生,都与使用BDZ的可能性增加有关。结论研究表明,巴基斯坦精神科门诊患者使用BDZ的比例很高。大多数用户使用它的时间和频率使他们有变得依赖BDZ的风险。在大多数情况下,这是由医生发起的。患者和医生都需要意识到与使用BDZ相关的依赖风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号